Formulation of liposomes functionalized with Lotus lectin and effective in targeting highly proliferative cells
Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative...
Saved in:
Published in | Biochimica et biophysica acta. General subjects Vol. 1861; no. 4; pp. 860 - 870 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.04.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative cells not detectable in normally growing cells. In contrast, other lectins localize the corresponding glycoepitopes all over the cell surface. LTL also proved able to penetrate the cells by an unconventional uptake mechanism.
We used confocal laser microscopy to detect and localize LTL-positive glycoepitopes and lectin uptake in two cancer cell lines. We then constructed doxorubicin-loaded liposomes functionalized with LTL. Intracellular delivery of the drug was determined in vitro and in vivo by confocal and electron microscopy.
We confirmed the specific localization of Lotus binding sites and the lectin uptake mechanism in the two cell lines and determined that LTL-functionalized liposomes loaded with doxorubicin greatly increased intracellular delivery of the drug, compared to unmodified doxorubicin-loaded liposomes. The LTL-Dox-L mechanism of entry and drug delivery was different to that of Dox-L and other liposomal preparations. LTL-Dox-L entered the cells one by one in tiny tubules that never fused with lysosomes. LTL-Dox-L injected in mice with melanoma specifically delivered loaded Dox to the cytoplasm of tumor cells.
Liposome functionalization with LTL promises to broaden the therapeutic potential of liposomal doxorubicin treatment, decreasing non-specific toxicity.
Doxorubicin-LTL functionalized liposomes promise to be useful in the development of new cancer chemotherapy protocols. |
---|---|
AbstractList | Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative cells not detectable in normally growing cells. In contrast, other lectins localize the corresponding glycoepitopes all over the cell surface. LTL also proved able to penetrate the cells by an unconventional uptake mechanism.BACKGROUNDLiposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative cells not detectable in normally growing cells. In contrast, other lectins localize the corresponding glycoepitopes all over the cell surface. LTL also proved able to penetrate the cells by an unconventional uptake mechanism.We used confocal laser microscopy to detect and localize LTL-positive glycoepitopes and lectin uptake in two cancer cell lines. We then constructed doxorubicin-loaded liposomes functionalized with LTL. Intracellular delivery of the drug was determined in vitro and in vivo by confocal and electron microscopy.METHODSWe used confocal laser microscopy to detect and localize LTL-positive glycoepitopes and lectin uptake in two cancer cell lines. We then constructed doxorubicin-loaded liposomes functionalized with LTL. Intracellular delivery of the drug was determined in vitro and in vivo by confocal and electron microscopy.We confirmed the specific localization of Lotus binding sites and the lectin uptake mechanism in the two cell lines and determined that LTL-functionalized liposomes loaded with doxorubicin greatly increased intracellular delivery of the drug, compared to unmodified doxorubicin-loaded liposomes. The LTL-Dox-L mechanism of entry and drug delivery was different to that of Dox-L and other liposomal preparations. LTL-Dox-L entered the cells one by one in tiny tubules that never fused with lysosomes. LTL-Dox-L injected in mice with melanoma specifically delivered loaded Dox to the cytoplasm of tumor cells.RESULTSWe confirmed the specific localization of Lotus binding sites and the lectin uptake mechanism in the two cell lines and determined that LTL-functionalized liposomes loaded with doxorubicin greatly increased intracellular delivery of the drug, compared to unmodified doxorubicin-loaded liposomes. The LTL-Dox-L mechanism of entry and drug delivery was different to that of Dox-L and other liposomal preparations. LTL-Dox-L entered the cells one by one in tiny tubules that never fused with lysosomes. LTL-Dox-L injected in mice with melanoma specifically delivered loaded Dox to the cytoplasm of tumor cells.Liposome functionalization with LTL promises to broaden the therapeutic potential of liposomal doxorubicin treatment, decreasing non-specific toxicity.CONCLUSIONSLiposome functionalization with LTL promises to broaden the therapeutic potential of liposomal doxorubicin treatment, decreasing non-specific toxicity.Doxorubicin-LTL functionalized liposomes promise to be useful in the development of new cancer chemotherapy protocols.GENERAL SIGNIFICANCEDoxorubicin-LTL functionalized liposomes promise to be useful in the development of new cancer chemotherapy protocols. Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative cells not detectable in normally growing cells. In contrast, other lectins localize the corresponding glycoepitopes all over the cell surface. LTL also proved able to penetrate the cells by an unconventional uptake mechanism. We used confocal laser microscopy to detect and localize LTL-positive glycoepitopes and lectin uptake in two cancer cell lines. We then constructed doxorubicin-loaded liposomes functionalized with LTL. Intracellular delivery of the drug was determined in vitro and in vivo by confocal and electron microscopy. We confirmed the specific localization of Lotus binding sites and the lectin uptake mechanism in the two cell lines and determined that LTL-functionalized liposomes loaded with doxorubicin greatly increased intracellular delivery of the drug, compared to unmodified doxorubicin-loaded liposomes. The LTL-Dox-L mechanism of entry and drug delivery was different to that of Dox-L and other liposomal preparations. LTL-Dox-L entered the cells one by one in tiny tubules that never fused with lysosomes. LTL-Dox-L injected in mice with melanoma specifically delivered loaded Dox to the cytoplasm of tumor cells. Liposome functionalization with LTL promises to broaden the therapeutic potential of liposomal doxorubicin treatment, decreasing non-specific toxicity. Doxorubicin-LTL functionalized liposomes promise to be useful in the development of new cancer chemotherapy protocols. Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative cells not detectable in normally growing cells. In contrast, other lectins localize the corresponding glycoepitopes all over the cell surface. LTL also proved able to penetrate the cells by an unconventional uptake mechanism.We used confocal laser microscopy to detect and localize LTL-positive glycoepitopes and lectin uptake in two cancer cell lines. We then constructed doxorubicin-loaded liposomes functionalized with LTL. Intracellular delivery of the drug was determined in vitro and in vivo by confocal and electron microscopy.We confirmed the specific localization of Lotus binding sites and the lectin uptake mechanism in the two cell lines and determined that LTL-functionalized liposomes loaded with doxorubicin greatly increased intracellular delivery of the drug, compared to unmodified doxorubicin-loaded liposomes. The LTL-Dox-L mechanism of entry and drug delivery was different to that of Dox-L and other liposomal preparations. LTL-Dox-L entered the cells one by one in tiny tubules that never fused with lysosomes. LTL-Dox-L injected in mice with melanoma specifically delivered loaded Dox to the cytoplasm of tumor cells.Liposome functionalization with LTL promises to broaden the therapeutic potential of liposomal doxorubicin treatment, decreasing non-specific toxicity.Doxorubicin-LTL functionalized liposomes promise to be useful in the development of new cancer chemotherapy protocols. |
Author | Finetti, Federica Ziche, Marina Magnani, Agnese Donnini, Sandra Rossi, Claudio Leone, Gemma Bonechi, Claudia Capone, Antonietta Rosati, Floriana Della Giovampaola, Cinzia Ermini, Leonardo Vannuccini, Elisa Lupetti, Pietro |
Author_xml | – sequence: 1 givenname: Cinzia surname: Della Giovampaola fullname: Della Giovampaola, Cinzia organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 2 givenname: Antonietta surname: Capone fullname: Capone, Antonietta organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 3 givenname: Leonardo surname: Ermini fullname: Ermini, Leonardo organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 4 givenname: Pietro surname: Lupetti fullname: Lupetti, Pietro organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 5 givenname: Elisa surname: Vannuccini fullname: Vannuccini, Elisa organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 6 givenname: Federica surname: Finetti fullname: Finetti, Federica organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 7 givenname: Sandra surname: Donnini fullname: Donnini, Sandra organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 8 givenname: Marina surname: Ziche fullname: Ziche, Marina organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 9 givenname: Agnese surname: Magnani fullname: Magnani, Agnese organization: Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 10 givenname: Gemma surname: Leone fullname: Leone, Gemma organization: Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 11 givenname: Claudio surname: Rossi fullname: Rossi, Claudio organization: Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 12 givenname: Floriana surname: Rosati fullname: Rosati, Floriana organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy – sequence: 13 givenname: Claudia surname: Bonechi fullname: Bonechi, Claudia email: claudia.bonechi@unisi.it organization: Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28095317$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcFu1DAQhi1URLeFN0DIRy67Hcexk3BAQhUFpJW4wNly7PGuV0682Emr8vQ43cKBQ2uNZM3M949G81-QszGOSMhbBhsGTF4dNn2vdzhuKmDNBlgJ8YKsWNtU6xZAnpEVcKjXNZPinFzkfIDyRCdekfOqhU5w1qxIvIlpmIOefBxpdDT4Y8xxwEzdPJqlqoP_jZbe-WlPt3GaMw1YGiPVo6Xo3JLcIi2FSacdls6O7v1uH-7pMcXgHSb9QBgMIb8mL50OGd88_pfk583nH9df19vvX75df9quTV2zac206NFWWnRd4yxD23e9bQXIxkjHuQFg3HWSuaq3puZgZc2gdsARZCUbyy_J-9PcssOvGfOkBp-XDfSIcc6qKrfgsgHePouyVjLRVKJpCvruEZ37Aa06Jj_odK_-3rMA9QkwKeac0P1DGKjFNnVQJ9vUYpsCVkIU2Yf_ZMZPD55MSfvwnPjjSYzlnrcek8rG42jQ-lTMUTb6pwf8AVAqtok |
CitedBy_id | crossref_primary_10_3390_nano11020289 crossref_primary_10_1039_C7RA12543G crossref_primary_10_1016_j_bpc_2019_106149 crossref_primary_10_3390_cancers14040911 crossref_primary_10_1016_j_molstruc_2019_127264 crossref_primary_10_3390_ph14090835 crossref_primary_10_1039_D0BM01531H crossref_primary_10_1016_j_mtcomm_2019_100634 crossref_primary_10_1002_adv_21965 crossref_primary_10_1016_j_bbagen_2023_130517 crossref_primary_10_1016_j_ijpharm_2024_124685 crossref_primary_10_1016_j_bpc_2019_01_002 crossref_primary_10_1016_j_yexcr_2020_112324 crossref_primary_10_1016_j_onano_2022_100080 crossref_primary_10_1016_j_jddst_2017_09_019 crossref_primary_10_1016_j_carbpol_2019_115347 crossref_primary_10_1016_j_carbpol_2024_121780 crossref_primary_10_1016_j_bpc_2024_107381 crossref_primary_10_1016_j_ntm_2024_100054 crossref_primary_10_1016_j_chembiol_2024_09_010 crossref_primary_10_1016_j_mehy_2018_05_002 crossref_primary_10_1080_00387010_2018_1556700 crossref_primary_10_1159_000513430 crossref_primary_10_1016_j_ijpharm_2021_120413 crossref_primary_10_3390_pharmaceutics13101617 crossref_primary_10_1080_00914037_2020_1848831 crossref_primary_10_1007_s00432_018_2726_1 crossref_primary_10_3390_biomedicines8120580 crossref_primary_10_2217_nnm_2019_0308 crossref_primary_10_1016_j_bpc_2017_11_003 |
Cites_doi | 10.1038/nrd1632 10.1016/0039-9140(96)01932-7 10.3109/02652049509010292 10.4103/0973-1482.139267 10.1063/1.1678153 10.1016/S0076-6879(07)38006-3 10.1146/annurev-pathol-012414-040438 10.3389/fphar.2015.00286 10.1038/nrd2897 10.1016/j.bbamem.2008.12.019 10.1016/B978-0-12-397945-2.00014-7 10.1073/pnas.78.7.4515 10.1371/journal.pone.0041438 10.7554/eLife.00090 10.1200/JCO.2001.19.5.1444 10.1016/j.addr.2003.10.015 10.1097/CAD.0000000000000182 10.1016/j.jconrel.2010.01.036 10.1016/j.juro.2011.05.040 10.1038/nrm2216 10.1038/227680a0 10.1016/j.ijpharm.2005.04.029 10.2310/7290.2010.00054 10.1097/FPC.0b013e32833ffb56 10.1016/j.biomaterials.2009.05.031 10.1016/S0169-409X(02)00042-X 10.3389/fchem.2014.00105 10.1016/j.acthis.2010.02.004 10.1002/pmic.201300387 10.1016/0009-3084(93)90064-A 10.1016/j.carbpol.2011.12.047 10.1093/glycob/cwp065 10.3109/10611860108997933 10.1016/j.addr.2016.04.014 10.1016/j.biotechadv.2013.01.005 10.1016/j.tice.2014.10.007 |
ContentType | Journal Article |
Copyright | 2017 Elsevier B.V. Copyright © 2017 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2017 Elsevier B.V. – notice: Copyright © 2017 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
DOI | 10.1016/j.bbagen.2017.01.015 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1872-8006 |
EndPage | 870 |
ExternalDocumentID | 28095317 10_1016_j_bbagen_2017_01_015 S0304416517300156 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABEFU ABFNM ABGSF ABMAC ABUDA ABXDB ABYKQ ACDAQ ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UQL WH7 WUQ XJT XPP ~G- AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH CGR CUY CVF ECM EFKBS EIF NPM 7X8 7S9 L.6 |
ID | FETCH-LOGICAL-c441t-1a5bed2a5997fd1edb9bd85067c6f33c0013f961f2bdc430d64104f03e06267d3 |
IEDL.DBID | .~1 |
ISSN | 0304-4165 |
IngestDate | Fri Jul 11 10:53:15 EDT 2025 Fri Jul 11 13:22:53 EDT 2025 Mon Jul 21 05:42:28 EDT 2025 Tue Jul 01 00:22:08 EDT 2025 Thu Apr 24 23:00:34 EDT 2025 Fri Feb 23 02:32:42 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | DOPE LTL LTL-Dex-L LTL-Dox-L Drug delivery Targeted liposomes Dox L Lotus lectin Doxorubicin NMR LTL-L Dex Dex-L DOPC Dox-L |
Language | English |
License | Copyright © 2017 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c441t-1a5bed2a5997fd1edb9bd85067c6f33c0013f961f2bdc430d64104f03e06267d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://hdl.handle.net/11365/1004600 |
PMID | 28095317 |
PQID | 1861572577 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2000367038 proquest_miscellaneous_1861572577 pubmed_primary_28095317 crossref_primary_10_1016_j_bbagen_2017_01_015 crossref_citationtrail_10_1016_j_bbagen_2017_01_015 elsevier_sciencedirect_doi_10_1016_j_bbagen_2017_01_015 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2017 2017-04-00 2017-Apr 20170401 |
PublicationDateYYYYMMDD | 2017-04-01 |
PublicationDate_xml | – month: 04 year: 2017 text: April 2017 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Biochimica et biophysica acta. General subjects |
PublicationTitleAlternate | Biochim Biophys Acta Gen Subj |
PublicationYear | 2017 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Torchilin (bb0005) 2005; 4 Batist, Ramakrishnan, Rao, Chandrasekharan, Gutheil, Guthrie, Shah, Khojasteh, Nair, Hoelzer, Tkaczuk, Park, Lee (bb0020) 2001; 19 Rivankar (bb0010) 2014; 10 Leone, Consumi, Lamponi, Magnani (bb0090) 2012; 88 Christiansen, Chik, Ling, Anugrahm, Abrahams, Packer (bb0040) 2014; 14 Langley (bb0095) 1992 Powlesland, Hitchen, Parry, Graham, Barrio, Elola, Mordoh, Dell, Drickamer, Taylor (bb0045) 2009; 19 Sahay, Alakhova, Kabanov (bb0170) 2010; 145 Koppel (bb0100) 1972; 57 Ghazarian, Idoni, Oppenheimer (bb0035) 2011; 113 Laemmli (bb0085) 1970; 27 Aldi, Capone, Della Giovampaola, Ermini, Pianigiani, Mariotti, Rosati (bb0070) 2015; 47 Bonechi, Ristori, Martini, Martini, Rossi (bb0135) 2009; 1788 Sercombe, Veerati, Moheimani, Wu, Sood, Hua (bb0160) 2015; 6 Stowell, Ju, Cummings (bb0050) 2011; 10 Bonechi, Martini, Ciani, Lamponi, Setzer, Rebmann, Rossi, Ristori (bb0075) 2012; 7 Tomoko, Fumiyoshi (bb0130) 2005; 298 Cevc (bb0120) 1993; 64 Rajendran, Knolker, Simons (bb0015) 2010; 9 Neutsch, Plattner, Polster-Wildhofen, Zidar, Chott, Borchard, Zechner, Gabor, Wirth (bb0180) 2011; 186 Tahover, Patil, Gabizon (bb0025) 2015; 26 Sastry, Lingeswara Rao (bb0105) 1996; 43 Gabor, Bogner, Weissenboech, Virth (bb0060) 2004; 56 Chun, Lee, Kim, Hong, Kim, Yang, Song (bb0140) 2009; 30 Sutherland, Delia, Schneider, Newman, Kemshead, Greaves (bb0155) 1981; 78 Conniot, Silva, Fernandez, Silva, Gaspar, Brocchini, Florindo, Barata (bb0030) 2014; 2 Levitt (bb0145) 2001 Lu, Low (bb0150) 2002; 54 Roney, Xu, Xie, Yuan, Wierwille, Chen, Griffiths, Summers (bb0055) 2011; 10 Gajbhiye, Gong (bb0065) 2013; 31 Kirchhausen, Macia, Pelish (bb0115) 2008; 438 Kulkarni, Betageri, Singh (bb0125) 1995; 12 Satyajit, Pagano (bb0185) 2007; 8 Hunter (bb0080) 1988 Beloqui, des Rieux, Préat (bb0165) 2016; 106 Thorn, Oshiro, Marsh, Hernandez-Boussard, McLeod, Klein, Altman (bb0190) 2011; 21 Brück, Abu-Dahab, Borchard, Schäfer, Lehr (bb0175) 2001; 9 Rogowski, Scholz, Geimer (bb0110) 2013; 524 Denard, Lee, Ye (bb0195) 2012; 1 Hunter (10.1016/j.bbagen.2017.01.015_bb0080) 1988 Bonechi (10.1016/j.bbagen.2017.01.015_bb0075) 2012; 7 Roney (10.1016/j.bbagen.2017.01.015_bb0055) 2011; 10 Gajbhiye (10.1016/j.bbagen.2017.01.015_bb0065) 2013; 31 Langley (10.1016/j.bbagen.2017.01.015_bb0095) 1992 Powlesland (10.1016/j.bbagen.2017.01.015_bb0045) 2009; 19 Leone (10.1016/j.bbagen.2017.01.015_bb0090) 2012; 88 Tomoko (10.1016/j.bbagen.2017.01.015_bb0130) 2005; 298 Sahay (10.1016/j.bbagen.2017.01.015_bb0170) 2010; 145 Sastry (10.1016/j.bbagen.2017.01.015_bb0105) 1996; 43 Kulkarni (10.1016/j.bbagen.2017.01.015_bb0125) 1995; 12 Satyajit (10.1016/j.bbagen.2017.01.015_bb0185) 2007; 8 Chun (10.1016/j.bbagen.2017.01.015_bb0140) 2009; 30 Neutsch (10.1016/j.bbagen.2017.01.015_bb0180) 2011; 186 Rajendran (10.1016/j.bbagen.2017.01.015_bb0015) 2010; 9 Tahover (10.1016/j.bbagen.2017.01.015_bb0025) 2015; 26 Levitt (10.1016/j.bbagen.2017.01.015_bb0145) 2001 Christiansen (10.1016/j.bbagen.2017.01.015_bb0040) 2014; 14 Denard (10.1016/j.bbagen.2017.01.015_bb0195) 2012; 1 Bonechi (10.1016/j.bbagen.2017.01.015_bb0135) 2009; 1788 Koppel (10.1016/j.bbagen.2017.01.015_bb0100) 1972; 57 Rivankar (10.1016/j.bbagen.2017.01.015_bb0010) 2014; 10 Torchilin (10.1016/j.bbagen.2017.01.015_bb0005) 2005; 4 Rogowski (10.1016/j.bbagen.2017.01.015_bb0110) 2013; 524 Brück (10.1016/j.bbagen.2017.01.015_bb0175) 2001; 9 Sercombe (10.1016/j.bbagen.2017.01.015_bb0160) 2015; 6 Ghazarian (10.1016/j.bbagen.2017.01.015_bb0035) 2011; 113 Gabor (10.1016/j.bbagen.2017.01.015_bb0060) 2004; 56 Cevc (10.1016/j.bbagen.2017.01.015_bb0120) 1993; 64 Stowell (10.1016/j.bbagen.2017.01.015_bb0050) 2011; 10 Batist (10.1016/j.bbagen.2017.01.015_bb0020) 2001; 19 Kirchhausen (10.1016/j.bbagen.2017.01.015_bb0115) 2008; 438 Lu (10.1016/j.bbagen.2017.01.015_bb0150) 2002; 54 Sutherland (10.1016/j.bbagen.2017.01.015_bb0155) 1981; 78 Aldi (10.1016/j.bbagen.2017.01.015_bb0070) 2015; 47 Conniot (10.1016/j.bbagen.2017.01.015_bb0030) 2014; 2 Beloqui (10.1016/j.bbagen.2017.01.015_bb0165) 2016; 106 Thorn (10.1016/j.bbagen.2017.01.015_bb0190) 2011; 21 Laemmli (10.1016/j.bbagen.2017.01.015_bb0085) 1970; 27 |
References_xml | – volume: 31 start-page: 552 year: 2013 end-page: 562 ident: bb0065 article-title: Lectin functionalized nanocarriers for gene delivery publication-title: Biotechnol. Adv. – volume: 57 start-page: 4814 year: 1972 end-page: 4820 ident: bb0100 article-title: Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants publication-title: J. Chem. Phys. – volume: 113 start-page: 236 year: 2011 end-page: 247 ident: bb0035 article-title: A glycobiology review: carbohydrates, lectins, and implications in cancer therapeutics publication-title: Acta Histochem. – volume: 145 start-page: 182 year: 2010 end-page: 195 ident: bb0170 article-title: Endocytosis of nanomedicines publication-title: J. Control. Release – volume: 43 start-page: 1827 year: 1996 end-page: 1835 ident: bb0105 article-title: Determination of doxorubicin hydrochloride by visible spectrophotometry publication-title: Talanta – volume: 10 start-page: 473 year: 2011 end-page: 510 ident: bb0050 article-title: Protein glycosylation in cancer publication-title: Annu. Rev. Pathol. – volume: 8 start-page: 603 year: 2007 end-page: 612 ident: bb0185 article-title: Pathways of clathrin-independent endocytosis publication-title: Nat. Rev. Mol. Cell Biol. – volume: 47 start-page: 33 year: 2015 end-page: 38 ident: bb0070 article-title: Identification of a novel, alpha2-fucosylation-dependent uptake system in highly proliferative cells publication-title: Tissue Cell – volume: 9 start-page: 241 year: 2001 end-page: 251 ident: bb0175 article-title: Lectin-functionalized liposomes for pulmonary drug delivery: interaction with human alveolar epithelial cells publication-title: J. Drug Target. – volume: 106 start-page: 242 year: 2016 end-page: 255 ident: bb0165 article-title: Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier publication-title: Adv. Drug Deliv. Rev. – volume: 19 start-page: 899 year: 2009 end-page: 909 ident: bb0045 article-title: Targeted glycoproteomic identification of cancer cell glycosylation publication-title: Glycobiology – volume: 4 start-page: 145 year: 2005 end-page: 160 ident: bb0005 article-title: Recent advances with liposomes as pharmaceutical carriers publication-title: Nat. Rev. Drug Discov. – volume: 298 start-page: 198 year: 2005 end-page: 205 ident: bb0130 article-title: Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method publication-title: Int. J. Pharm. – year: 1988 ident: bb0080 article-title: Zeta Potential in Colloid Science: Principles And Application – volume: 56 start-page: 459 year: 2004 end-page: 480 ident: bb0060 article-title: The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery publication-title: Adv. Drug Deliv. Rev. – volume: 1788 start-page: 708 year: 2009 end-page: 716 ident: bb0135 article-title: Study of bradykinin conformation in the presence of model membrane by Nuclear Magnetic Resonance and molecular modeling publication-title: Biochim. Biophys. Acta – volume: 9 start-page: 29 year: 2010 end-page: 42 ident: bb0015 article-title: Subcellular targeting strategies for drug design and delivery publication-title: Nat. Rev. Drug Discov. – volume: 524 start-page: 243 year: 2013 end-page: 263 ident: bb0110 article-title: Electron microscopy of flagella, primary cilia, and intraflagellar transport in flat-embedded cells publication-title: Methods Enzymol. – start-page: 151 year: 1992 end-page: 160 ident: bb0095 article-title: Developments in electrophoretic laser light scattering and some of biochemical applications publication-title: Laser Light Scattering in Biochemistry – volume: 78 start-page: 4515 year: 1981 end-page: 4519 ident: bb0155 article-title: Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferring publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 14 start-page: 525 year: 2014 end-page: 546 ident: bb0040 article-title: Cell surface protein glycosylation in cancer publication-title: Proteomics – volume: 21 start-page: 440 year: 2011 end-page: 446 ident: bb0190 article-title: Doxorubicin pathways: pharmacodynamics and adverse effects publication-title: Pharmacogenet. Genomics – volume: 54 start-page: 675 year: 2002 end-page: 693 ident: bb0150 article-title: Folate-mediated delivery of macromolecular anticancer therapeutic agents publication-title: Adv. Drug Deliv. Rev. – volume: 6 start-page: 286 year: 2015 end-page: 289 ident: bb0160 article-title: Advances and challenges of liposome assisted drug delivery publication-title: Front. Pharmacol. – volume: 88 start-page: 799 year: 2012 end-page: 808 ident: bb0090 article-title: New hyaluroran derivative with prolonged half-life for ophthalmological formulation publication-title: Carbohydr. Polym. – volume: 438 start-page: 77 year: 2008 end-page: 93 ident: bb0115 article-title: Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis publication-title: Methods Enzymol. – year: 2001 ident: bb0145 article-title: Basic of nuclear magnetic resonance – volume: 64 start-page: 163 year: 1993 end-page: 186 ident: bb0120 article-title: Electrostatic characterization of liposomes publication-title: Chem. Phys. Lipids – volume: 30 start-page: 4752 year: 2009 end-page: 4762 ident: bb0140 article-title: Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics publication-title: Biomaterials – volume: 26 start-page: 241 year: 2015 end-page: 258 ident: bb0025 article-title: Emerging delivery systems to reduce Doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes publication-title: Anticancer Drugs – volume: 27 start-page: 680 year: 1970 end-page: 685 ident: bb0085 article-title: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4 publication-title: Nature – volume: 7 start-page: e41438 year: 2012 ident: bb0075 article-title: Using liposomes as carriers for polyphenolic compounds: the case of trans-resveratrol publication-title: PLoS One – volume: 12 start-page: 229 year: 1995 end-page: 246 ident: bb0125 article-title: Factors affecting microencapsulation of drugs in liposomes publication-title: J. Microencapsul. – volume: 10 start-page: 853 year: 2014 end-page: 858 ident: bb0010 article-title: An overview of Doxorubicin formulation in cancer therapy publication-title: J. Cancer Res. Ther. – volume: 19 start-page: 1444 year: 2001 end-page: 1454 ident: bb0020 article-title: Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated Doxorubicin and cyclo phosphamide compared with conventional Doxorubicin and cyclo phosphamide in a randomized multicenter trial of metastatic breast cancer publication-title: J. Clin. Oncol. – volume: 186 start-page: 1481 year: 2011 end-page: 1488 ident: bb0180 article-title: Lectin mediated biorecognition as a novel strategy for targeted delivery to bladder cancer publication-title: J. Urol. – volume: 2 start-page: 105 year: 2014 end-page: 132 ident: bb0030 article-title: Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking publication-title: Front. Chem. – volume: 1 start-page: e00090 year: 2012 ident: bb0195 article-title: Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1 publication-title: eLife Sci. – volume: 10 start-page: 305 year: 2011 end-page: 316 ident: bb0055 article-title: Rh-I-UEA-1 polymerized liposomes target and image adenomatous polyps in the APC(Min/+) mouse using optical colonography publication-title: Mol. Imaging – volume: 4 start-page: 145 year: 2005 ident: 10.1016/j.bbagen.2017.01.015_bb0005 article-title: Recent advances with liposomes as pharmaceutical carriers publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd1632 – volume: 43 start-page: 1827 year: 1996 ident: 10.1016/j.bbagen.2017.01.015_bb0105 article-title: Determination of doxorubicin hydrochloride by visible spectrophotometry publication-title: Talanta doi: 10.1016/0039-9140(96)01932-7 – volume: 12 start-page: 229 year: 1995 ident: 10.1016/j.bbagen.2017.01.015_bb0125 article-title: Factors affecting microencapsulation of drugs in liposomes publication-title: J. Microencapsul. doi: 10.3109/02652049509010292 – volume: 10 start-page: 853 year: 2014 ident: 10.1016/j.bbagen.2017.01.015_bb0010 article-title: An overview of Doxorubicin formulation in cancer therapy publication-title: J. Cancer Res. Ther. doi: 10.4103/0973-1482.139267 – volume: 57 start-page: 4814 year: 1972 ident: 10.1016/j.bbagen.2017.01.015_bb0100 article-title: Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants publication-title: J. Chem. Phys. doi: 10.1063/1.1678153 – volume: 438 start-page: 77 year: 2008 ident: 10.1016/j.bbagen.2017.01.015_bb0115 article-title: Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis publication-title: Methods Enzymol. doi: 10.1016/S0076-6879(07)38006-3 – volume: 10 start-page: 473 year: 2011 ident: 10.1016/j.bbagen.2017.01.015_bb0050 article-title: Protein glycosylation in cancer publication-title: Annu. Rev. Pathol. doi: 10.1146/annurev-pathol-012414-040438 – volume: 6 start-page: 286 year: 2015 ident: 10.1016/j.bbagen.2017.01.015_bb0160 article-title: Advances and challenges of liposome assisted drug delivery publication-title: Front. Pharmacol. doi: 10.3389/fphar.2015.00286 – volume: 9 start-page: 29 year: 2010 ident: 10.1016/j.bbagen.2017.01.015_bb0015 article-title: Subcellular targeting strategies for drug design and delivery publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2897 – year: 2001 ident: 10.1016/j.bbagen.2017.01.015_bb0145 – volume: 1788 start-page: 708 year: 2009 ident: 10.1016/j.bbagen.2017.01.015_bb0135 article-title: Study of bradykinin conformation in the presence of model membrane by Nuclear Magnetic Resonance and molecular modeling publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbamem.2008.12.019 – volume: 524 start-page: 243 year: 2013 ident: 10.1016/j.bbagen.2017.01.015_bb0110 article-title: Electron microscopy of flagella, primary cilia, and intraflagellar transport in flat-embedded cells publication-title: Methods Enzymol. doi: 10.1016/B978-0-12-397945-2.00014-7 – volume: 78 start-page: 4515 year: 1981 ident: 10.1016/j.bbagen.2017.01.015_bb0155 article-title: Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferring publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.78.7.4515 – volume: 7 start-page: e41438 year: 2012 ident: 10.1016/j.bbagen.2017.01.015_bb0075 article-title: Using liposomes as carriers for polyphenolic compounds: the case of trans-resveratrol publication-title: PLoS One doi: 10.1371/journal.pone.0041438 – volume: 1 start-page: e00090 year: 2012 ident: 10.1016/j.bbagen.2017.01.015_bb0195 article-title: Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1 publication-title: eLife Sci. doi: 10.7554/eLife.00090 – volume: 19 start-page: 1444 year: 2001 ident: 10.1016/j.bbagen.2017.01.015_bb0020 article-title: Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated Doxorubicin and cyclo phosphamide compared with conventional Doxorubicin and cyclo phosphamide in a randomized multicenter trial of metastatic breast cancer publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2001.19.5.1444 – year: 1988 ident: 10.1016/j.bbagen.2017.01.015_bb0080 – volume: 56 start-page: 459 year: 2004 ident: 10.1016/j.bbagen.2017.01.015_bb0060 article-title: The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2003.10.015 – volume: 26 start-page: 241 year: 2015 ident: 10.1016/j.bbagen.2017.01.015_bb0025 article-title: Emerging delivery systems to reduce Doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes publication-title: Anticancer Drugs doi: 10.1097/CAD.0000000000000182 – start-page: 151 year: 1992 ident: 10.1016/j.bbagen.2017.01.015_bb0095 article-title: Developments in electrophoretic laser light scattering and some of biochemical applications – volume: 145 start-page: 182 year: 2010 ident: 10.1016/j.bbagen.2017.01.015_bb0170 article-title: Endocytosis of nanomedicines publication-title: J. Control. Release doi: 10.1016/j.jconrel.2010.01.036 – volume: 186 start-page: 1481 year: 2011 ident: 10.1016/j.bbagen.2017.01.015_bb0180 article-title: Lectin mediated biorecognition as a novel strategy for targeted delivery to bladder cancer publication-title: J. Urol. doi: 10.1016/j.juro.2011.05.040 – volume: 8 start-page: 603 year: 2007 ident: 10.1016/j.bbagen.2017.01.015_bb0185 article-title: Pathways of clathrin-independent endocytosis publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm2216 – volume: 27 start-page: 680 year: 1970 ident: 10.1016/j.bbagen.2017.01.015_bb0085 article-title: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4 publication-title: Nature doi: 10.1038/227680a0 – volume: 298 start-page: 198 year: 2005 ident: 10.1016/j.bbagen.2017.01.015_bb0130 article-title: Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2005.04.029 – volume: 10 start-page: 305 year: 2011 ident: 10.1016/j.bbagen.2017.01.015_bb0055 article-title: Rh-I-UEA-1 polymerized liposomes target and image adenomatous polyps in the APC(Min/+) mouse using optical colonography publication-title: Mol. Imaging doi: 10.2310/7290.2010.00054 – volume: 21 start-page: 440 year: 2011 ident: 10.1016/j.bbagen.2017.01.015_bb0190 article-title: Doxorubicin pathways: pharmacodynamics and adverse effects publication-title: Pharmacogenet. Genomics doi: 10.1097/FPC.0b013e32833ffb56 – volume: 30 start-page: 4752 year: 2009 ident: 10.1016/j.bbagen.2017.01.015_bb0140 article-title: Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics publication-title: Biomaterials doi: 10.1016/j.biomaterials.2009.05.031 – volume: 54 start-page: 675 year: 2002 ident: 10.1016/j.bbagen.2017.01.015_bb0150 article-title: Folate-mediated delivery of macromolecular anticancer therapeutic agents publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(02)00042-X – volume: 2 start-page: 105 year: 2014 ident: 10.1016/j.bbagen.2017.01.015_bb0030 article-title: Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking publication-title: Front. Chem. doi: 10.3389/fchem.2014.00105 – volume: 113 start-page: 236 year: 2011 ident: 10.1016/j.bbagen.2017.01.015_bb0035 article-title: A glycobiology review: carbohydrates, lectins, and implications in cancer therapeutics publication-title: Acta Histochem. doi: 10.1016/j.acthis.2010.02.004 – volume: 14 start-page: 525 year: 2014 ident: 10.1016/j.bbagen.2017.01.015_bb0040 article-title: Cell surface protein glycosylation in cancer publication-title: Proteomics doi: 10.1002/pmic.201300387 – volume: 64 start-page: 163 year: 1993 ident: 10.1016/j.bbagen.2017.01.015_bb0120 article-title: Electrostatic characterization of liposomes publication-title: Chem. Phys. Lipids doi: 10.1016/0009-3084(93)90064-A – volume: 88 start-page: 799 year: 2012 ident: 10.1016/j.bbagen.2017.01.015_bb0090 article-title: New hyaluroran derivative with prolonged half-life for ophthalmological formulation publication-title: Carbohydr. Polym. doi: 10.1016/j.carbpol.2011.12.047 – volume: 19 start-page: 899 year: 2009 ident: 10.1016/j.bbagen.2017.01.015_bb0045 article-title: Targeted glycoproteomic identification of cancer cell glycosylation publication-title: Glycobiology doi: 10.1093/glycob/cwp065 – volume: 9 start-page: 241 year: 2001 ident: 10.1016/j.bbagen.2017.01.015_bb0175 article-title: Lectin-functionalized liposomes for pulmonary drug delivery: interaction with human alveolar epithelial cells publication-title: J. Drug Target. doi: 10.3109/10611860108997933 – volume: 106 start-page: 242 year: 2016 ident: 10.1016/j.bbagen.2017.01.015_bb0165 article-title: Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2016.04.014 – volume: 31 start-page: 552 year: 2013 ident: 10.1016/j.bbagen.2017.01.015_bb0065 article-title: Lectin functionalized nanocarriers for gene delivery publication-title: Biotechnol. Adv. doi: 10.1016/j.biotechadv.2013.01.005 – volume: 47 start-page: 33 year: 2015 ident: 10.1016/j.bbagen.2017.01.015_bb0070 article-title: Identification of a novel, alpha2-fucosylation-dependent uptake system in highly proliferative cells publication-title: Tissue Cell doi: 10.1016/j.tice.2014.10.007 |
SSID | ssj0000595 |
Score | 2.3613305 |
Snippet | Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 860 |
SubjectTerms | Animals Binding Sites Cell Line, Tumor Cell Proliferation - drug effects Chemistry, Pharmaceutical - methods confocal laser scanning microscopy Cytoplasm - drug effects Doxorubicin Doxorubicin - administration & dosage Doxorubicin - chemistry Drug delivery Drug Delivery Systems - methods drug therapy Epitopes - administration & dosage Epitopes - chemistry Fabaceae - metabolism fucose Humans lectins Lectins - administration & dosage Lectins - chemistry Liposomes - administration & dosage Liposomes - chemistry Lotus lectin Lotus tetragonolobus lysosomes Lysosomes - drug effects melanoma Melanoma, Experimental - drug therapy Mice NMR polysaccharides Targeted liposomes |
Title | Formulation of liposomes functionalized with Lotus lectin and effective in targeting highly proliferative cells |
URI | https://dx.doi.org/10.1016/j.bbagen.2017.01.015 https://www.ncbi.nlm.nih.gov/pubmed/28095317 https://www.proquest.com/docview/1861572577 https://www.proquest.com/docview/2000367038 |
Volume | 1861 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS-wwEB9Ekfcu4sd7un4RwWveNv3YbI-yuKyfFxW8haRJobK2i9096MG_3ZmmVQRFeNBLQwJhJpn5ZTL5DcBxbIRJRSo5-uKAx8PA8dQYx10ausgE2oomm_DqejC5i8_vk_slGHVvYSitsrX93qY31rpt6bfS7M-Kon9Dl3oIJxJBlOt4DKEX7LGkVf7v9SPNA-FD4m8SYk69u-dzTY6XMbhpiQVVyIa8k4rjfu2evoOfjRsar8Naix_ZiZ_iBiy5chNWfUXJ5034NeoKuG1BNUY82lbnYlXOpsWsqqtHVzNyZj4GWLw4yygWyy6r-aJmFMQvSqZLy3ymBxpDhg0-YRzdHCN-4-kzm1G1n9x53nBG4f_6D9yNT29HE97WV-AZCm7OhU6Ms6FO0lTmVjhrUmOJwU5mgzyKMoKHeToQeWhshqq0gxgPb3kQuQCPQdJGf2G5rEq3AyzQhja31lmCPQTqWNskykTsEI7KMO5B1IlVZS35ONXAmKouy-xBeWUoUoYKBH5JD_j7qJkn3_ihv-w0pj4tIoX-4YeRR52CFWqJpKZLVy1qJYaI-SQaNvl9n7Ch9UHbOezBtl8d7_MNh8ToJ-Tuf89tD37Tn08X2ofl-dPCHSASmpvDZqkfwsrJ2cXk-g3-Fghm |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED7alNK9jK1du-ynCnsVsWwrih9LWEjXNC9roW9CsmTwSO1QJw_tX987y-4orBQGfpJPIO6ku0_S6TuAH6kVNhOZ4hiLI55OIs8zaz33WewTGxkn2mzCy-V4fp3-upE3OzDt38JQWmXn-4NPb7111zLqtDlal-XoN13qIZyQgijXcRuyC3vETiUHsHd2fjFf_nXIsi2-QvKcOvQv6No0L2tx3RIRqlAtfyfVx_13hHoJgbaRaPYO3nYQkp2FUb6HHV8dwn4oKnl_CAfTvobbEdQzhKRdgS5WF2xVruumvvUNo3gWjgHLB-8YHceyRb3ZNozO8cuKmcqxkOyB_pBhQ8gZx0jHiOJ4dc_WVPCn8IE6nNENQPMBrmc_r6Zz3pVY4DnqbsOFkda72MgsU4UT3tnMOiKxU_m4SJKcEGKRjUURW5ejNd04xf1bESU-wp2QcskxDKq68h-BRcbS-jYmlygh0MzGySQXqUdEquJ0CEmvVp13_ONUBmOl-0SzPzoYQ5MxdCTwk0PgT73WgX_jFXnVW0w_m0caQ8QrPU97A2u0EmnNVL7eNlpMEPYp9G3qZZm4ZfZB9zkZwkmYHU_jjSdE6ifUp_8e23c4mF9dLvTifHnxGd7Qn5A99AUGm7ut_4rAaGO_dRP_EQLCCxc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Formulation+of+liposomes+functionalized+with+Lotus+lectin+and+effective+in+targeting+highly+proliferative+cells&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Della+Giovampaola%2C+Cinzia&rft.au=Capone%2C+Antonietta&rft.au=Ermini%2C+Leonardo&rft.au=Lupetti%2C+Pietro&rft.date=2017-04-01&rft.issn=0304-4165&rft.volume=1861&rft.issue=4&rft.spage=860&rft_id=info:doi/10.1016%2Fj.bbagen.2017.01.015&rft_id=info%3Apmid%2F28095317&rft.externalDocID=28095317 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon |